APC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_APC_091809
C57BL/6 bone marrow cells stained with 1A8 APC
  • 1A8_APC_091809
    C57BL/6 bone marrow cells stained with 1A8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
127613 25 µg £61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127614 100 µg £215
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Patras KA, et al. 2019. J Innate Immun. :1. PubMed
  2. Yu‐Han Chang et al. 2017. Immunity. 47(5):943-958 . PubMed
  3. Li A, et al. 2020. Oncol Lett. 1.899305556. PubMed
  4. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  5. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  6. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  7. Wenzek C, et al. 2022. iScience. 25:105540. PubMed
  8. Ding Z, et al. 2021. Int J Mol Sci. 22:. PubMed
  9. Cornax I, et al. 2021. Microorganisms. 9:00. PubMed
  10. Stein K, et al. 2016. J Leukoc Biol. 99: 231 - 239. PubMed
  11. Christian D, et al. 2014. Infect Immun . 82:4056. PubMed
  12. Sharma A, et al. 2014. J Infect Dis. . PubMed
  13. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  14. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  15. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  16. Poli V, et al. 2021. iScience. 24:103256. PubMed
  17. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  18. Weiss M, et al. 2015. Proc Natl Acad Sci U S A. 112: 11001-11006. PubMed
  19. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  20. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  21. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  22. Han J, et al. 2022. FEBS J. 289:417. PubMed
  23. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  24. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  25. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  26. Meng L, et al. 2021. Front Oncol. 11:691705. PubMed
  27. Mathur S, et al. 2021. JCI Insight. 6:. PubMed
  28. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  29. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  30. Patnode M, et al. 2014. J Exp Med. 211:1281. PubMed
  31. Liao H, et al. 2015. Rheumatology. 54: 1317 - 1326. PubMed
  32. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  33. Thompson ER, et al. 2020. Am J Transplant. . PubMed
  34. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  35. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  36. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  37. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  38. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  39. Yao ME, et al. 2022. Evid Based Complement Alternat Med. 2022:7784148. PubMed
  40. Pawaria S, et al. 2020. Arthritis Rheumatol. 72:359. PubMed
  41. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  42. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  43. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  44. Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
  45. Ma Y, et al. 2016. Cardiovasc Res. 110: 51 - 61. PubMed
  46. Karmakar M, et al. 2016. Nat Commun. 7:10555. PubMed
  47. Chu C, et al. 2016. Dis Model Mech. 9: 473-481. PubMed
  48. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  49. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  50. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  51. Michael BD, et al. 2020. Cell Reports. 32(11):108150. PubMed
  52. Uceda-Castro R, et al. 2022. Cell Rep Med. 3:100821. PubMed
  53. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  54. Goldman E, et al. 2021. Cells. 10:. PubMed
  55. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  56. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  57. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  58. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  59. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  60. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  61. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  62. Gottfried-Blackmore A, et al. 2009. Proc Natl Acad Sci U S A. 106:20918. PubMed
  63. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  64. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  65. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  66. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  67. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  68. Guo P, et al. 2021. J Immunol. 207:408. PubMed
  69. Cui C, et al. 2021. Cell. 184(12):3163-3177.e21. PubMed
  70. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  71. Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
  72. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  73. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  74. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  75. Wang SS et al. 2018. Cell chemical biology. 25(12):1519-1532 . PubMed
  76. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  77. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  78. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  79. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  80. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  81. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  82. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  83. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  84. Zhou Q, et al. 2014. J Immunol. 193:496. PubMed
  85. Li H, et al. 2019. Front Immunol. 2.205555556. PubMed
  86. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  87. Cho K, et al. 2021. iScience. 24:103117. PubMed
  88. Gurusamy M, et al. 2021. Nat Commun. 12:6798. PubMed
  89. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  90. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  91. Xiao Y, et al. 2022. Dis Markers. 2022:1380560. PubMed
  92. Bolkhovitina EL, et al. 2022. Int J Mol Sci. 23: . PubMed
  93. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  94. Price P, et al. 2015. J Immunol. 194:1164. PubMed
  95. Albarrán-Juárez J, et al. 2016. Atherosclerosis. 251:445-53. PubMed
  96. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  97. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  98. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  99. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  100. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  101. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  102. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  103. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  104. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  105. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  106. Steichen A, et al. 2015. PLoS One. 10:123573. PubMed
  107. Cohen M, et al. 2014. EMBO J. 33:2906. PubMed
  108. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
  109. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  110. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  111. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  112. Namiguchi K, et al. 2022. Front Cardiovasc Med. 8:761591. PubMed
  113. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  114. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  115. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  116. Wang SS, et al. 2021. Cell Chemical Biology. 28(5):699-710.e5. PubMed
  117. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  118. Bitschar K, et al. 2019. Nat Commun. 10:2730. PubMed
  119. Wingrove E et al. 2019. Cell reports. 27(4):1277-1292 . PubMed
  120. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  121. Ohno-Urabe S, et al. 2018. J Am Heart Assoc. 7:e007389. PubMed
  122. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  123. Qadir AS, et al. 2021. iScience. 24:103348. PubMed
  124. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  125. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  126. Resende M, et al. 2019. J Immunol. 203:2451. PubMed
  127. Salvagno C, et al. 2019. Nat Cell Biol. 1.229861111. PubMed
  128. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  129. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  130. Georgiadou A, et al. 2022. Elife. 11:. PubMed
  131. Kwon MY, et al. 2021. J Leukoc Biol. 110:711. PubMed
  132. Skokowa J, et al. 2022. Nat Commun. 13:2948. PubMed
  133. Lin T, et al. 2021. PLoS Pathog. 17:e1009557. PubMed
  134. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  135. Chua Y, et al. 2016. J Immunol. 197: 3771 - 3781. PubMed
  136. Ulrich V, et al. 2016. EMBO Mol Med. 8: 643 - 653. PubMed
  137. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  138. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  139. Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
  140. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  141. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  142. Kamei A, et al. 2012. J Infect Dis. 207:39. PubMed
  143. Gardner P, et al. 2015. Am J Pathol. 185:1324. PubMed
  144. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  145. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  146. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  147. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  148. Molgora M, et al. 2020. Cell. 182:886. PubMed
  149. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  150. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  151. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  152. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  153. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  154. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  155. Wang M, et al. 2021. iScience. 24(7):102766. PubMed
  156. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  157. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  158. Zhang J et al. 2019. Cell Rep. 27(9):2679-2689 . PubMed
  159. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  160. Oertli M, et al. 2011. J Immunol. 187:3578. PubMed
  161. Phadke MS, et al. 2021. Cancer Immunol Res. 9:554. PubMed
  162. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  163. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  164. Cardoso M, et al. 2015. Infect Immun . 83: 3534-3544. PubMed
  165. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  166. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  167. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  168. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  169. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  170. Wang S, et al. 2022. Blood. 140:171. PubMed
  171. Liao YC, et al. 2021. Front Immunol. 12:743030. PubMed
  172. Young K, et al. 2021. Cell Stem Cell. . PubMed
  173. Cardoso F, et al. 2015. PLoS One. 10: 0131904. PubMed
  174. Devi S, et al. 2013. J Exp Med. 210:2321. PubMed
RRID
AB_1877163 (BioLegend Cat. No. 127613)
AB_2227348 (BioLegend Cat. No. 127614)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01/06/2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account